Anthropic has released the first results from its AI biology lab, and the discovery is a genuinely new finding: a previously unknown DNA system hidden inside bacteria-infecting viruses. The work was led by Claude agents, with human scientists acting as supervisors and verification.
What Claude Found
Claude agents searched a DNA database and stumbled across a stretch of repeating genetic code inside viruses that infect bacteria. The pattern bore a striking resemblance to CRISPR — the gene-editing system that has already revolutionised medicine. The finding was so surprising that one of the AI agents annotating the data wrote: “that’s a CRISPR-like … repeat array?!”
The enzyme itself was already on record in scientific databases. But Claude appears to be the first to recognise the broader genetic context around it — a combination of DNA features only found in systems that “cut, copy, and paste DNA.” That context is what makes the finding potentially significant.
Anthropic’s CEO Dario Amodei confirmed the system, which the team has named ART, could represent a new class of gene editor. He described the work as “mostly, though not entirely” Claude’s, with scientists choosing the research question and running the experiments that Claude itself suggested.
950 Agents in Less Than a Day
Anthropic deployed roughly 950 AI agents for less than 24 hours to comb through the genetic data. The agents consumed around 210 million tokens of compute. One of those agents — the one reading the genetic code near a particular enzyme — made the call that triggered the discovery.
Amodei described the result as “work I would have been proud to do as a PhD student.” That statement captures the significance: an AI is now producing contributions that a human researcher would be proud to claim as their thesis work, in a fraction of the time.
Why This Matters
The finding sits at a critical inflection point for AI-driven research. Amodei noted that AI models have progressed from failing basic mathematics in 2023 to cracking some of the hardest open scientific questions today. OpenAI recently reported AI solving over 100 complex math problems — and now biology appears to be following the same trajectory.
CRISPR-based gene editing is already responsible for a wave of new medicines targeting previously untreatable genetic conditions. If ART turns out to be a functional gene-editing system, it could open an entirely new branch of that field. But even Anthropic admits it does not yet know what the system actually does.
What matters more than the specific finding is the pattern. AI agents are now doing original research at the frontier of biology, completing work in hours that would take human scientists months or years. This is where genuinely world-altering discoveries begin to emerge — and they are now happening on AI time.
The Broader Picture
The discovery comes alongside another Anthropic report showing that Claude now “leads” 26 percent of the company’s own AI research and development — completing tasks end-to-end from a simple prompt while a human supervises. That figure was under 1 percent in February. The company also reported roughly 30,000 AI agents running across its research and engineering operations, with all actions monitored and one in 47,000 blocked by safety systems.
Anthropic has been vocal about the risks of recursive self-improvement in AI. Last week it called for a slowdown. This week it published evidence that the process is already well underway on its own side. The tension between public caution and internal acceleration is one of the defining dynamics of the AI industry right now.
What is no longer in question is that AI agents can do real science. The question now is what happens when they do it faster than humans can check the results.
